Acarbose-Induced Glucagon-Like Peptide-1 Secretion Contributes to the Glucose-Lowering Effect of Acarbose

被引：2
|
作者：
Dalsgaard, Niels B.
Gasbjerg, Laerke S.
Hansen, Laura S.
Hansen, Nina L.
Stensen, Signe
Hartmann, Bolette
Holst, Jens J.
Vilsboll, Tina
Knop, Filip K.
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-1145-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1145-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin
    Bahne, Emilie
    Hansen, Morten
    Bronden, Andreas
    Sonne, David P.
    Vilsboll, Tina
    Knop, Filip K.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (10): : 955 - 961
  • [2] Effects of voglibose and acarbose on glucose homeostasis and glucagon-like peptide-1 secretion in NIDDM patients
    Goke, B
    Kleist, P
    Littke, T
    Stridde, E
    Haupt, E
    [J]. DIABETOLOGIA, 1997, 40 : 507 - 507
  • [3] An osmotic stimulus-mediating glucagon-like peptide-1 (7-36 amide) (GLP-1) secretion in acarbose-induced sucrose malabsorption?
    Ranganath, L
    Morgan, L
    [J]. NUTRITION, 2000, 16 (01) : 64 - 65
  • [4] The Glucose-Lowering Effect of the Bile Acid Sequestrant Sevelamer Is Not Mediated by Glucagon-Like Peptide-1
    Nerild, Henriette H.
    Bronden, Andreas
    Sonne, David P.
    Holst, Jens J.
    Vilsboll, Tina
    Knop, Filip K.
    [J]. DIABETES, 2021, 70
  • [5] A mutated glucagon-like peptide-1 with improved glucose-lowering activity in diabetic mice
    Gao, Mingming
    Tong, Yue
    Gao, Xiangdong
    Yao, Wenbing
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2013, 65 (04) : 539 - 546
  • [6] EFFECT OF GLUCAGON ON SECRETION OF GLUCAGON-LIKE PEPTIDE-1
    SHIMA, K
    OHBOSHI, C
    SATO, M
    HIROTA, M
    [J]. HORMONE AND METABOLIC RESEARCH, 1988, 20 (02) : 123 - 124
  • [7] Glucagon-like peptide-1 response to acarbose in elderly type 2 diabetic subjects
    DeLeon, MJ
    Chandurkar, V
    Albert, SG
    Mooradian, AD
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 56 (02) : 101 - 106
  • [8] Association of glucagon-like peptide-1 receptor-targeted imaging probe with in vivo glucagon-like peptide-1 receptor agonist glucose-lowering effects
    Murakami, Takaaki
    Fujimoto, Hiroyuki
    Fujita, Naotaka
    Hamamatsu, Keita
    Yabe, Daisuke
    Inagaki, Nobuya
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (06) : 1448 - 1456
  • [9] Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes
    Zander, M
    Taskiran, M
    Toft-Nielsen, MB
    Madsbad, S
    Holst, JJ
    [J]. DIABETES CARE, 2001, 24 (04) : 720 - 725
  • [10] The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide-1 Contribute Equally to Its Glucose-Lowering Action
    Hare, Kristine J.
    Vilsboll, Tina
    Asmar, Meena
    Deacon, Carolyn F.
    Knop, Filip K.
    Holst, Jens J.
    [J]. DIABETES, 2010, 59 : A439 - A439
12345